Click for best price
Recombinant DNA Technology Market Size, Share 2023
| Market size in 2022 |
US$ 505 million
|
Forecast Market size by 2029 |
US$ 653.1 million
|
| Growth Rate |
CAGR of 3.7% |
Number of Pages |
104 Pages |
The global Recombinant DNA Technology market was valued at US$ 505 million in 2022 and is projected to reach US$ 653.1 million by 2029, at a CAGR of 3.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Recombinant DNA Technology market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Recombinant DNA Technology market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Recombinant DNA Technology market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Recombinant DNA Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA Technology. This report contains market size and forecasts of Recombinant DNA Technology in global, including the following market information:
- Global Recombinant DNA Technology Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Therapeutic Agent Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant DNA Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant DNA Technology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Recombinant DNA Technology Market Segment Percentages, by Type, 2022 (%)
- Therapeutic Agent
- Vaccine
- Biotech Crops
- Specialty Chemicals
Global Recombinant DNA Technology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Recombinant DNA Technology Market Segment Percentages, by Application, 2022 (%)
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
- Others
Global Recombinant DNA Technology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Recombinant DNA Technology Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Recombinant DNA Technology revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Recombinant DNA Technology revenues share in global market, 2022 (%)
key players include:
- Monsanto Company
- Roche
- Biogen
- Amgen
- Novartis
- Eli Lilly and Company
- GenScript
- Pfizer Inc.
- Novo Nordisk
- Sanofi
- Merck KGaA
- Profacgen
- Biocon
- GlaxoSmithKline
- Cibus
- Horizon Discovery Group
- New England Biolabs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant DNA Technology, market overview.
Chapter 2: Global Recombinant DNA Technology market size in revenue.
Chapter 3: Detailed analysis of Recombinant DNA Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant DNA Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Recombinant DNA Technology Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 505 million
|
| Forecast Market size by 2029 |
US$ 653.1 million
|
| Growth Rate |
CAGR of 3.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
104 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant DNA Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant DNA Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant DNA Technology Overall Market Size
2.1 Global Recombinant DNA Technology Market Size: 2022 VS 2032
2.2 Global Recombinant DNA Technology Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant DNA Technology Players in Global Market
3.2 Top Global Recombinant DNA Technology Companies Ranked by Revenue
3.3 Global Recombinant DNA Technology Revenue by Companies
3.4 Top 3 and Top 5 Recombinant DNA Technology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant DNA Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant DNA Technology Players in Global Market
3.6.1 List of Global Tier 1 Recombinant DNA Technology Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant DNA Technology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant DNA Technology Market Size Markets, 2022 & 2032
4.1.2 Therapeutic Agent
4.1.3 Vaccine
4.1.4 Biotech Crops
4.1.5 Specialty Chemicals
4.2 By Type - Global Recombinant DNA Technology Revenue & Forecasts
4.2.1 By Type - Global Recombinant DNA Technology Revenue, 2018-2023
4.2.2 By Type - Global Recombinant DNA Technology Revenue, 2024-2032
4.2.3 By Type - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant DNA Technology Market Size, 2022 & 2032
5.1.2 Biotechnology and Pharmaceutical Companies
5.1.3 Academic & Government Research Institutes
5.1.4 Others
5.2 By Application - Global Recombinant DNA Technology Revenue & Forecasts
5.2.1 By Application - Global Recombinant DNA Technology Revenue, 2018-2023
5.2.2 By Application - Global Recombinant DNA Technology Revenue, 2024-2032
5.2.3 By Application - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Recombinant DNA Technology Market Size, 2022 & 2032
6.2 By Region - Global Recombinant DNA Technology Revenue & Forecasts
6.2.1 By Region - Global Recombinant DNA Technology Revenue, 2018-2023
6.2.2 By Region - Global Recombinant DNA Technology Revenue, 2024-2032
6.2.3 By Region - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Recombinant DNA Technology Revenue, 2018-2032
6.3.2 US Recombinant DNA Technology Market Size, 2018-2032
6.3.3 Canada Recombinant DNA Technology Market Size, 2018-2032
6.3.4 Mexico Recombinant DNA Technology Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Recombinant DNA Technology Revenue, 2018-2032
6.4.2 Germany Recombinant DNA Technology Market Size, 2018-2032
6.4.3 France Recombinant DNA Technology Market Size, 2018-2032
6.4.4 U.K. Recombinant DNA Technology Market Size, 2018-2032
6.4.5 Italy Recombinant DNA Technology Market Size, 2018-2032
6.4.6 Russia Recombinant DNA Technology Market Size, 2018-2032
6.4.7 Nordic Countries Recombinant DNA Technology Market Size, 2018-2032
6.4.8 Benelux Recombinant DNA Technology Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Recombinant DNA Technology Revenue, 2018-2032
6.5.2 China Recombinant DNA Technology Market Size, 2018-2032
6.5.3 Japan Recombinant DNA Technology Market Size, 2018-2032
6.5.4 South Korea Recombinant DNA Technology Market Size, 2018-2032
6.5.5 Southeast Asia Recombinant DNA Technology Market Size, 2018-2032
6.5.6 India Recombinant DNA Technology Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Recombinant DNA Technology Revenue, 2018-2032
6.6.2 Brazil Recombinant DNA Technology Market Size, 2018-2032
6.6.3 Argentina Recombinant DNA Technology Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant DNA Technology Revenue, 2018-2032
6.7.2 Turkey Recombinant DNA Technology Market Size, 2018-2032
6.7.3 Israel Recombinant DNA Technology Market Size, 2018-2032
6.7.4 Saudi Arabia Recombinant DNA Technology Market Size, 2018-2032
6.7.5 UAE Recombinant DNA Technology Market Size, 2018-2032
7 Recombinant DNA Technology Companies Profiles
7.1 Monsanto Company
7.1.1 Monsanto Company Company Summary
7.1.2 Monsanto Company Business Overview
7.1.3 Monsanto Company Recombinant DNA Technology Major Product Offerings
7.1.4 Monsanto Company Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.1.5 Monsanto Company Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Recombinant DNA Technology Major Product Offerings
7.2.4 Roche Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Biogen
7.3.1 Biogen Company Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Recombinant DNA Technology Major Product Offerings
7.3.4 Biogen Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.3.5 Biogen Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Recombinant DNA Technology Major Product Offerings
7.4.4 Amgen Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Recombinant DNA Technology Major Product Offerings
7.5.4 Novartis Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Company Summary
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company Recombinant DNA Technology Major Product Offerings
7.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly and Company Key News & Latest Developments
7.7 GenScript
7.7.1 GenScript Company Summary
7.7.2 GenScript Business Overview
7.7.3 GenScript Recombinant DNA Technology Major Product Offerings
7.7.4 GenScript Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.7.5 GenScript Key News & Latest Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Company Summary
7.8.2 Pfizer Inc. Business Overview
7.8.3 Pfizer Inc. Recombinant DNA Technology Major Product Offerings
7.8.4 Pfizer Inc. Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.8.5 Pfizer Inc. Key News & Latest Developments
7.9 Novo Nordisk
7.9.1 Novo Nordisk Company Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Recombinant DNA Technology Major Product Offerings
7.9.4 Novo Nordisk Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.9.5 Novo Nordisk Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Recombinant DNA Technology Major Product Offerings
7.10.4 Sanofi Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Company Summary
7.11.2 Merck KGaA Business Overview
7.11.3 Merck KGaA Recombinant DNA Technology Major Product Offerings
7.11.4 Merck KGaA Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.11.5 Merck KGaA Key News & Latest Developments
7.12 Profacgen
7.12.1 Profacgen Company Summary
7.12.2 Profacgen Business Overview
7.12.3 Profacgen Recombinant DNA Technology Major Product Offerings
7.12.4 Profacgen Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.12.5 Profacgen Key News & Latest Developments
7.13 Biocon
7.13.1 Biocon Company Summary
7.13.2 Biocon Business Overview
7.13.3 Biocon Recombinant DNA Technology Major Product Offerings
7.13.4 Biocon Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.13.5 Biocon Key News & Latest Developments
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Company Summary
7.14.2 GlaxoSmithKline Business Overview
7.14.3 GlaxoSmithKline Recombinant DNA Technology Major Product Offerings
7.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.14.5 GlaxoSmithKline Key News & Latest Developments
7.15 Cibus
7.15.1 Cibus Company Summary
7.15.2 Cibus Business Overview
7.15.3 Cibus Recombinant DNA Technology Major Product Offerings
7.15.4 Cibus Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.15.5 Cibus Key News & Latest Developments
7.16 Horizon Discovery Group
7.16.1 Horizon Discovery Group Company Summary
7.16.2 Horizon Discovery Group Business Overview
7.16.3 Horizon Discovery Group Recombinant DNA Technology Major Product Offerings
7.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.16.5 Horizon Discovery Group Key News & Latest Developments
7.17 New England Biolabs
7.17.1 New England Biolabs Company Summary
7.17.2 New England Biolabs Business Overview
7.17.3 New England Biolabs Recombinant DNA Technology Major Product Offerings
7.17.4 New England Biolabs Recombinant DNA Technology Revenue in Global Market (2018-2023)
7.17.5 New England Biolabs Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Recombinant DNA Technology Market Opportunities & Trends in Global Market
Table 2. Recombinant DNA Technology Market Drivers in Global Market
Table 3. Recombinant DNA Technology Market Restraints in Global Market
Table 4. Key Players of Recombinant DNA Technology in Global Market
Table 5. Top Recombinant DNA Technology Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Recombinant DNA Technology Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Recombinant DNA Technology Revenue Share by Companies, 2018-2023
Table 8. Global Companies Recombinant DNA Technology Product Type
Table 9. List of Global Tier 1 Recombinant DNA Technology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant DNA Technology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant DNA Technology Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Recombinant DNA Technology Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Recombinant DNA Technology Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Recombinant DNA Technology Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Recombinant DNA Technology Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Recombinant DNA Technology Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Recombinant DNA Technology Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Recombinant DNA Technology Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Recombinant DNA Technology Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Recombinant DNA Technology Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Recombinant DNA Technology Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Recombinant DNA Technology Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Recombinant DNA Technology Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Recombinant DNA Technology Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Recombinant DNA Technology Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Recombinant DNA Technology Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Recombinant DNA Technology Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Recombinant DNA Technology Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Recombinant DNA Technology Revenue, (US$, Mn), 2024-2032
Table 30. Monsanto Company Company Summary
Table 31. Monsanto Company Recombinant DNA Technology Product Offerings
Table 32. Monsanto Company Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 33. Monsanto Company Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Recombinant DNA Technology Product Offerings
Table 36. Roche Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Biogen Company Summary
Table 39. Biogen Recombinant DNA Technology Product Offerings
Table 40. Biogen Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 41. Biogen Key News & Latest Developments
Table 42. Amgen Company Summary
Table 43. Amgen Recombinant DNA Technology Product Offerings
Table 44. Amgen Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 45. Amgen Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Recombinant DNA Technology Product Offerings
Table 48. Novartis Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Eli Lilly and Company Company Summary
Table 51. Eli Lilly and Company Recombinant DNA Technology Product Offerings
Table 52. Eli Lilly and Company Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly and Company Key News & Latest Developments
Table 54. GenScript Company Summary
Table 55. GenScript Recombinant DNA Technology Product Offerings
Table 56. GenScript Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 57. GenScript Key News & Latest Developments
Table 58. Pfizer Inc. Company Summary
Table 59. Pfizer Inc. Recombinant DNA Technology Product Offerings
Table 60. Pfizer Inc. Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Inc. Key News & Latest Developments
Table 62. Novo Nordisk Company Summary
Table 63. Novo Nordisk Recombinant DNA Technology Product Offerings
Table 64. Novo Nordisk Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 65. Novo Nordisk Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Recombinant DNA Technology Product Offerings
Table 68. Sanofi Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Merck KGaA Company Summary
Table 71. Merck KGaA Recombinant DNA Technology Product Offerings
Table 72. Merck KGaA Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 73. Merck KGaA Key News & Latest Developments
Table 74. Profacgen Company Summary
Table 75. Profacgen Recombinant DNA Technology Product Offerings
Table 76. Profacgen Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 77. Profacgen Key News & Latest Developments
Table 78. Biocon Company Summary
Table 79. Biocon Recombinant DNA Technology Product Offerings
Table 80. Biocon Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 81. Biocon Key News & Latest Developments
Table 82. GlaxoSmithKline Company Summary
Table 83. GlaxoSmithKline Recombinant DNA Technology Product Offerings
Table 84. GlaxoSmithKline Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 85. GlaxoSmithKline Key News & Latest Developments
Table 86. Cibus Company Summary
Table 87. Cibus Recombinant DNA Technology Product Offerings
Table 88. Cibus Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 89. Cibus Key News & Latest Developments
Table 90. Horizon Discovery Group Company Summary
Table 91. Horizon Discovery Group Recombinant DNA Technology Product Offerings
Table 92. Horizon Discovery Group Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 93. Horizon Discovery Group Key News & Latest Developments
Table 94. New England Biolabs Company Summary
Table 95. New England Biolabs Recombinant DNA Technology Product Offerings
Table 96. New England Biolabs Recombinant DNA Technology Revenue (US$, Mn) & (2018-2023)
Table 97. New England Biolabs Key News & Latest Developments
List of Figures
Figure 1. Recombinant DNA Technology Segment by Type in 2022
Figure 2. Recombinant DNA Technology Segment by Application in 2022
Figure 3. Global Recombinant DNA Technology Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant DNA Technology Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Recombinant DNA Technology Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2022
Figure 8. By Type - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 9. By Application - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 10. By Type - Global Recombinant DNA Technology Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 12. By Application - Global Recombinant DNA Technology Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 14. By Region - Global Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 15. By Country - North America Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 16. US Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 20. Germany Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 21. France Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 28. China Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 32. India Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 34. Brazil Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Recombinant DNA Technology Revenue Market Share, 2018-2032
Figure 37. Turkey Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Recombinant DNA Technology Revenue, (US$, Mn), 2018-2032
Figure 41. Monsanto Company Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biogen Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Amgen Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly and Company Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GenScript Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Inc. Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novo Nordisk Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck KGaA Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Profacgen Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Biocon Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. GlaxoSmithKline Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Cibus Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Horizon Discovery Group Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. New England Biolabs Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
